Successful treatment with low-dose imatinib mesylate of therapy-related myeloid neoplasm harboring TEL-PDGFRB in a patient with acute promyelocytic leukemia.
Asou
Norio
N
Iwanaga
Eisaku
E
Nanri
Tomoko
T
Mitsuya
Hiroaki
H
D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D015473:Leukemia, Promyelocytic, Acute / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000175:diagnosis / Q000188:drug therapy*; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D012074:Remission Induction / Q000379:methods
D001549:Benzamides; D015514:Oncogene Proteins, Fusion; D010879:Piperazines; D011743:Pyrimidines; C120888:TEL-PDGFRbeta fusion protein, human; D000068877:Imatinib Mesylate
Blood. 2007 Jan 1;109(1):61-4
16960151
Haematologica. 2009 Apr;94(4):454-9
19336749
Cancer Cell. 2005 Feb;7(2):129-41
15710326
Haematologica. 2009 Mar;94(3):433-5
19181784
N Engl J Med. 2002 Aug 15;347(7):481-7
12181402
Acta Haematol. 2008;119(1):57-9
18268406
Blood. 2002 Feb 1;99(3):822-4
11806982
Blood. 2007 Jul 1;110(1):59-66
17374742
Int J Hematol. 2009 Jun;89(5):699-703
19430863
Br J Haematol. 2009 Dec;147(5):681-5
19735261
Am J Hematol. 2007 Mar;82(3):248-9
16924641
Leukemia. 2003 Aug;17(8):1600-4
12886249